The insured entrance is online! The maximum guarantee is 3.3 million! "Health and Buddha Medical Insurance" is coming.

Waiting for a year, finally returning!

"Health and Buddha Medical Insurance" in 2024

Officially launched today! ! !

Before enrollment

Let’s take a look at the answers to these questions first

Question 1

What is the nature of "Health and Buddha Medical Insurance"?

"Health and Buddha Medical Insurance" is a commercial medical insurance product approved by the Foshan Municipal People’s Government and jointly directed by Foshan Medical Insurance Bureau, Foshan Supervision Branch of the State Financial Supervision and Management Bureau, Foshan Financial Work Bureau and Foshan Social Insurance Fund Management Bureau. According to Foshan’s medical and living standards, it is highly connected with Foshan’s basic medical insurance and serious illness insurance policies, improving the city’s medical security level, effectively reducing the medical expenses burden of people suffering from major diseases, and providing millions of insurance coverage at inclusive prices to improve the health of Foshan residents.

Question 2

Which insurance companies underwrite "Health Buddha Medical Insurance"?

"Health Buddha Medical Insurance" was jointly underwritten by six insurance companies. Among them, China Life Insurance Co., Ltd. Guangdong Branch is the main underwriting company; It is jointly underwritten by China People’s Property Insurance Co., Ltd. Guangdong Branch, China Pacific Property Insurance Co., Ltd. Guangdong Branch, China Ping An Property Insurance Co., Ltd. Guangdong Branch, China United Property Insurance Co., Ltd. Guangdong Branch and Taiping Property Insurance Co., Ltd.

Q 3

I bought "Health Buddha Medical Insurance" this year. Do I need to buy it again next year?

The guarantee period of "Health Buddha Medical Insurance" is one year, so if you buy "Health Buddha Medical Insurance" this year, you need to buy it again next year. If the insured who pays through the medical insurance account checks "Auto Re-insurance" in the enrollment interface, he will agree to participate in the subsequent annual "Health Buddha Medical Insurance" by default and authorize the system to automatically handle the enrollment and payment procedures.

Q 4

Who can participate in "Health Buddha Medical Insurance"?

Persons who meet one of the following conditions can apply for "Health-Buddha Medical Insurance" commercial medical insurance according to the relevant policies and regulations in accordance with the principle of voluntariness (no age limit, no previous illness limit):

1 Foshan basic medical insurance insured;

2. Foshan registered residents who participate in the basic medical insurance in other overall plans;

3. Other new citizens who have participated in the basic medical insurance as a whole and hold a valid residence permit in Foshan as of March 31, 2024;

4. Foshan students who have participated in the basic medical insurance as a whole in other places;

5. Other high-level talents in this city who participated in the basic medical insurance as a whole and were selected into the national, provincial and municipal talent plans at all levels, as well as all kinds of talents in this city who hold Guangdong Talents Excellent Guangdong Card and Foshan Talents Green Card;

6 by the relevant departments of this Municipality identified as courageous people within the administrative area of this Municipality.

7 other medical security system to protect the personnel.

During the insurance period, the insurance contract is invalid for those who are not in line with the actual situation or the insurance conditions of "Health Buddha Medical Insurance", do not assume the insurance responsibility and return the full premium paid.

Q 5

What is the coverage of "Health Buddha Medical Insurance"?

The protection of "Health Buddha Medical Insurance" covers: compensation for personal medical expenses within the scope of medical insurance catalogue, compensation for personal expenses outside the scope of medical insurance catalogue, compensation for self-funded drugs for specific diseases, compensation for ultra-high medical expenses, and compensation responsibility for high medical expenses in general outpatient departments.

Health management value-added services:

First, early cancer screening

Second, medical services

Third, health services

Fourth, life service

(The details and implementation time of the above value-added services are subject to the announcement of "Health Buddha Medical Insurance" WeChat WeChat official account. )

Question 6

You already have medical insurance, do you still need to buy "Health Buddha Medical Insurance"?

Basic medical insurance can’t cover all the medical expenses of the insured. After being reimbursed by medical insurance, the insured still has to bear the remaining medical expenses.

"Health and Buddha Medical Insurance" is closely linked with basic medical insurance. After medical insurance reimbursement, the insured’s medical expenses can not only continue to reimburse the remaining compliant medical expenses, but also cover the self-funded medical compensation for specific diseases, effectively alleviating the economic pressure caused by serious diseases to the insured. In order to provide themselves with more health insurance, it is recommended that all eligible insured persons actively purchase a "Health Buddha Medical Insurance".

Q 7

Is there any conflict between "Health Buddha Medical Insurance" and other commercial health insurance? What’s the difference with other commercial health insurance?

There is no conflict. The medical expenses incurred by the insured can be claimed by different commercial health medical insurance products, but the total amount of compensation accumulated after multiple claims will not exceed the total medical expenses of the insured. The coverage of "Health Buddha Medical Insurance" is in parallel with the protection of other commercial medical health insurance. After medical insurance reimbursement and other insurance products claim, you can apply for compensation from "Health Buddha Medical Insurance".

The difference between "Health Buddha Medical Insurance" and other commercial medical insurance lies in:

(1) Age of insurance: "Health Buddha Medical Insurance" has no age limit for the insured, and other commercial medical insurance generally has an age limit for the insured.

(2) Past illness: Insured persons with past illness can also apply for "Health Buddha Medical Insurance". Medical expenses arising from past illness can be claimed normally, while other commercial medical insurance does not cover the insured with past illness.

(3) Waiting period: There is no waiting period for "Health Buddha Medical Insurance", and other commercial medical insurance generally has a waiting period of 30 days or more.

(4) Insurance premium: "Health Buddha Medical Insurance" does not distinguish between age and sex, and the unified price is 185 yuan/person/year. The insurance premium of other commercial medical insurance is generally differentiated by age and sex, and the older you are, the higher the premium is.

Question 8

Insurance and guarantee time

Insurance time:

March 21, 2024 to April 30, 2024

Guarantee time:

00: 00 on January 1, 2024 to 24: 00 on December 31, 2024.

You can pass

"Foshan Release" WeChat WeChat official account

Insure

Method 1: Send the keyword "Buddha Medical Insurance" in the background, and click the link below to participate in the insurance.

Method 2: Click on the menu bar [Convenience Interaction]-[Health Buddha Medical Insurance] to participate in the insurance.

·

Recommended reading

Found a very small photo graffiti! It is very compatible with the vernal equinox. In 2024, "Health and Buddha Medical Insurance" came! Treatment optimization +5! Beneficiaries +2! Value-added health management!

Original title: "The insured entrance is online! The maximum guarantee is 3.3 million! "Health Buddha Medical Insurance" is coming "

Read the original text

The first preview of Xiaomi SU7 Ultra production version was released on October 29th.

Lei Jun released a brand-new official map of Ultra production in Weibo on October 28th. This is the first official picture of the production version, from which we can see the changes of many production models.

From the previous photos of the prototype of Xiaomi SU7 Ultra, it can be found that the prototype has a huge GT tail. Exaggerated diffusers and side skirts, tires are not street tires but hot-melt tires dedicated to the track. These exaggerated details are really in line with the identity of the prototype, and everything is for faster lap times.

Obviously, these kits can’t get on the road legally, and this preview also confirms this. The preview mainly shows the tail and side details of the production model, and many differences can be clearly found. First of all, the oversized GT tail wing was replaced by a more conservative small tail wing, and the wind knives on both sides of the prototype were also replaced by a folding design.

In addition, the rear enclosure has been replaced by the production version of ordinary SU7, and the giant diffuser below has disappeared. It seems that the side skirts and side air ducts have also been replaced with the style of ordinary SU7.

It can be seen that this prototype mass production has made many compromises in appearance, and a large number of aerodynamic kits have also been replaced.

However, the V8s motor used in the prototype should be retained, and the acceleration of 0-100km/h should still be expected to run within 2s by using the three-motor plus four-wheel drive.

The new car will be unveiled at the Xiaomi new product launch conference on October 29, and the actual performance can be expected.

The FDA’s annual inventory came, and 37 innovative drugs were approved! The domestic new drug "going out to sea" was a success, and these two domestic pharmaceutical companies lit up.

Recently, the FDA released the annual report on new drugs in 2022. The data shows that the FDA approved 37 innovative drugs to be listed last year, with the number reaching a new low of nearly six years, of which nearly 50% have been listed in China or are in the review stage. The FDA promotes and speeds up the evaluation of new drugs in various ways through "multi-pronged approach". In 2022, a number of domestic innovative drugs "went out to sea" to break through the FDA, and the results were "mixed". Two domestic innovative drugs were approved by the FDA and four hit a wall.

Figure 1: Number of new drugs approved by FDA in recent ten years

45491674084710448

Source: FDA2022 Annual Report on New Drugs (New Drug Therapy Approvals 2022).

37 innovative drugs were approved, and 18 accelerated the entry into the China market.

Recently, the Center for Drug Evaluation and Research (CDER) of FDA released the annual report of new drugs in 2022. In 2022, the FDA approved the listing of 37 innovative drugs, with the number reaching a new low of nearly six years. Among the approved innovative drugs, 20 (54%) belong to "first-in-class" innovative drugs, and 20 (54%) are drugs for rare diseases.

As the benchmark of global pharmaceutical supervision, FDA has approved 28 new drugs (76%) in the first round, and 25 (68%) in the United States before other countries.

In 2022, FDA promoted and accelerated the evaluation of new drugs in various ways through "multi-pronged approach". Twelve (32%) were identified as fast-track, 13 (35%) were identified as breakthrough therapeutic drugs, 21 (57%) were identified as priority review, and 6 (16%) were accelerated for approval. CDER used one or more accelerated development and review methods for 24 (65%) of all new drugs approved in 2022.

Table 1: Innovative Drugs Approved by FDA in 2022

98651674084710515

29821674084710717

9221674084710820

77661674084710920

Source: FDA website, intranet database.

In recent years, more and more attention has been paid to innovative drugs in China. In 2022, innovative drugs approved in the United States are also running into the China market at "China speed" to solve the unmet health needs of more China patients. According to statistics, at present, 18 (49%) innovative drugs are at the stage of clinical application and above in China. Among them, four innovative drugs, namely, abcixinib, voronoxan, benvimod and pessolizumab, have been approved for marketing, while otconazole and deuterium colexitinib are in the application stage, while nine innovative drugs are in clinical phase III, one in clinical phase I and two in clinical application.

Table 2: Research and Development of Innovative Drugs in China

40401674084710995

Source: Minenet database

Two domestic innovative drugs "went to sea" successfully, and legendary creatures actively expanded their territory.

In 2022, a number of domestic innovative drugs "went out to sea" broke through the FDA, and Sidakio Orense and Benvimod returned gratifying news and were successfully approved for listing.

On February 28th, 2022, the BCMA CAR-T drug Cedactylosin developed by Kingsley’s Legendary Biology was approved by FDA for the treatment of relapsed or refractory multiple myeloma. Cedactylosin became the first cell therapy product approved by FDA in China and the second CAR-T cell immunotherapy approved for BCMA in the world. This is a beautiful "turnaround" after the FDA announced the tightening of China’s listing policy for innovative drugs, which means that China has officially entered the world’s first-line position in the field of cell therapy.

After the successful listing in the United States, Sida Chiolense also extended its listing territory to the European Union and Japan in 2022. In May, 2022, the European Commission (EC) has granted conditional marketing permission to Cedactylosin for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least three treatments in the past, including immunomodulatory drugs, proteasome inhibitors and anti-CD38 antibodies, and the last treatment showed disease progression. In September, 2022, the Japanese Ministry of Health, Labor and Welfare approved Cedactylosin for the treatment of adult patients with recurrent or refractory multiple myeloma. At present, in China, Sida Chiolense is in the stage of applying for listing.

Figure 2: Global R&D progress of Sida Chiolense.

87341674084711042

77311674084711093

31201674084711159

On May 24th, 2022, Dermavant Sciences announced that the FDA had approved the marketing of VTAMA (Benvimod, 1%) cream for the local treatment of adult plaque psoriasis. Benvimod, developed by Tianji Medicine, a domestic enterprise, is the first-in-class new drug with independent intellectual property rights.

In 2012, GSK obtained the overseas development right of Benvimod with a down payment of nearly $200 million. In July 2018, GSK announced that it would sell the overseas development right of Benvimod to Dermavant for $330 million.

As early as May 2019, Benvimod was approved to be listed in China as a "Class 1 new drug" for adults with mild to moderate stability psoriasis vulgaris suitable for local treatment. So far, benvimod is the first innovative drug approved by the FDA after it was approved for marketing in China.

Figure 3: Global listing of Benvimod

50321674084711209

The road to "going out to sea" is not smooth. Cinda Bio and Junshi Bio … find another way out.

The road to "going out to sea" was not smooth sailing. In 2022, the innovative drugs of Cinda Bio, Junshi Bio, Hutchison Whampoa and Baekje Shenzhou all submitted their applications for listing in the FDA, but they were rejected by the FDA one after another.

Table 3: Drugs not approved by FDA in 2022

58801674084711274

In March, 2022, Cinda Bio announced that FDA refused to approve the listing application of new drugs for the first-line treatment of patients with non-squamous non-small cell lung cancer, including cindilizumab combined with pemetrexed and platinum chemotherapy. In its reply to Cinda Bio, FDA pointed out that the related product trials of Cinda Bio were only conducted in China, not global multi-center clinical trials, and the results were not applicable to patients in the United States due to the nature of a single country.

In May, 2022, Hutchison announced that the US FDA had not approved the application of Suo Fan tinib for the marketing of new drugs for the treatment of pancreatic and non-pancreatic neuroendocrine tumors. The reason for FDA’s rejection of Hutchison is similar to Cinda Bio’s. It thinks that the data package of Hutchison based on two successful China Phase III studies and an American bridging study is not enough to support the drug’s approval in the United States, and more international multi-center clinical trials representing American patients need to be included to support the approval in the United States.

In the same month, Junshi Bio’s application for the marketing of PD-1 antibody Treprilizumab received a complete reply from FDA, requesting a quality control process change. This process change was rejected because the facilities could not be inspected on site due to travel restrictions during COVID-19.

In July, 2022, Baekje Shenzhou announced that the FDA of the United States could not complete the required on-site verification work in China as scheduled due to travel restrictions related to the COVID-19 epidemic, so it would extend the completion time of the target review of the application for the new drug listing license for second-line esophageal squamous cell carcinoma. However, its partner Novartis revealed in the quarterly report that it had cancelled the listing application for the treatment of non-small cell lung cancer with tierellizumab in the United States.

In the face of the "ruthless" rejection of the FDA, Junshi Bio quickly made adjustment measures and resubmitted the application for the listing of Trepril monoclonal antibody to the US FDA. The FDA has set the date of PDUFA as December 23rd, 2022. Trepril monoclonal antibody is still in the approval stage, and there is no clear result. Hutchison Whampoa said that it is working with the FDA to evaluate the next step. Baekje Shenzhou is rumored to move to Europe, and it is expected that it will submit its first listing application in the EU in 2023. Cinda Bio announced at the end of the year that it had recovered the overseas rights and interests of Cindilizumab from its partner Lilly Pharmaceutical.

There are many cases of domestic innovative drugs failing to go to sea. On the one hand, FDA has high requirements for domestic pharmaceutical companies’ products going to sea. According to the FDA’s previous requirements for Cinda Bio, if the new PD-1 wants to be listed in the United States, it needs to compete with the existing standard therapies. And drug K has been approved for dozens of indications in the United States, and products with the same indications have to cross the mountain of drug K if they want to be approved. On the other hand, at present, how to conduct clinical trials of domestic innovative drugs overseas is still in the exploratory stage. These failed cases essentially reflect the doubts of foreign mature markets on the quality of clinical trials in China.

tag

2022 has passed, and the innovative drugs approved by FDA are the direction of global innovative drug research and development trends, leading the way for innovative pharmaceutical companies. For domestic innovative pharmaceutical companies, if they want their products to go abroad, there is no doubt that they should sum up their previous experience in innovating drugs in the FDA, always pay attention to the changes in the clinical pattern, and keep in touch with the FDA for clinical design. At the same time, we should improve our products from many dimensions, such as reflecting the innovation of products, meeting unmet clinical needs, improving drug accessibility, improving technology, selecting indications, and improving safety and efficacy.

Source: Minenet comprehensive database.

This article is an original manuscript, please indicate the source and author, otherwise the tort liability will be investigated.

The business routine of "lending to reduce interest rates" for mortgage loans has been refurbished, and many banks have prompted the risks of loan intermediaries.

"Houses in the whole region can operate at an annual rate of 3.2%" and "after the holiday, the interest rate on loans is as low as 2.9%". After the interest rate cut on existing mortgages, some loan intermediaries "renovated" their routines on social platforms and continued to attract customers with low-interest gimmicks.

Zhuoling (pseudonym), the owner of a new site in a town in Dongguan, Guangdong Province, has recently received similar "lending" business calls. He told reporters that most of these calls claimed to be the channel manager of a bank at the beginning, introducing "internal" or "year-end welfare" loan products, saying that these products have internal approval channels and can also be used to help mortgage loans cut interest rates again.

But in fact, these loan intermediaries are not related to banks, but induce consumers to carry out a series of illegal operations under the layers of internal approval, high and low interest. Recently, banks in Henan, Hubei, Guizhou and other places issued statements to remind consumers of the risks of loan intermediaries, and denied cooperation with intermediaries in loan business.

"Renovation" Routine of Lending Intermediary

Recently, the First Financial Reporter contacted a number of loan intermediaries in Guangdong on the grounds of consulting business, and found that behind the "lending and interest rate reduction" business provided by some intermediaries, mortgage loans were actually converted into business loans, that is, consumers were guided to use bridge funds to settle their mortgages, and then their houses were mortgaged to banks in the name of corporate legal persons and shareholders, and business loans were lent to banks.

These institutions take "loan interest rate reduction" as the main gimmick to attract customers. In an interview in March this year, the above-mentioned loan intermediaries advertised that the annualized interest rate of operating loans after lending was mostly between 3.4% and 3.8%, but in recent interviews, they claimed that the annualized interest rate of operating loans could be applied for below 3%.

"Recently, the market as a whole has cut interest rates, and the operating loan interest rate has been further lowered, which is a good opportunity for lending." An intermediary of a lending institution in Guangzhou told reporters that if the mortgage is 2.3 million yuan and the annualized interest rate is 4.5%, it can be adjusted to 2.9% after the interest rate cut, and it can save 33,000 yuan a year, which can save nearly 900,000 yuan in interest.

She introduced that at present, her institution can contact the bank to plan two types of business loans: 10-year interest first, then principal, and 20-year equal repayment, with interest rates of 2.9%. However, after specific consultation, the reporter found that even if the series of conditions are met, the real interest rate is between 3.1% and 3.3%.

In addition to low interest rates as a gimmick, some loan intermediaries also took advantage of the opportunity to lower the interest rate of existing mortgage loans, trying to mislead customers by packaging the official identity of banks and confusing concepts.

One of them, Yue Qiu (a pseudonym), a loan intermediary who claimed to be the channel loan staff of the state-owned bank, told reporters that they had "internal relations" in the bank and could lower the mortgage interest rate on the current basis. At the same time, there will be a special person to follow up, which can help customers speed up the approval of bank loan applications and follow up the prepayment process when handling the related business of "lending and interest rate reduction", thus controlling the cost of bridge-crossing funds.

"We have banking channels. After you submit an application for prepayment, we can help you to expedite it." According to him, they will also confirm the operating loan amount that can be applied for in the new bank through the information of the real estate license. If customers need it, they can also help to raise the price of real estate assessment for "over-lending", and besides covering the amount of repayment in advance, they can also make some extra funds.

The reporter verified the above statement with the financial manager of a branch of a state-owned bank in South China. The financial manager said that the bank’s prepayment and lending processes usually have specific approval links, so it is difficult to directly interfere. Many promises of these loan intermediaries are basically "fudge". Most of them are only familiar with the operation procedures and loan policies of banks, and use this to guide consumers to conduct illegal operations, and the ultimate risk will still be borne by consumers.

There are many risks.

Why are some loan intermediaries still recommending the "lending" business after the interest rate cut of existing mortgage loans? Many insiders believe that it is mainly related to the existing spread space.

The above-mentioned Guangzhou loan intermediary said that although some customers stopped lending plans after the interest rate reduction of existing mortgage loans, the operating loan interest rate has also been declining recently, and the preferential strength is strong, and there is still a spread between the interest rate and the lowered mortgage interest rate.

Lou Feipeng, a research institute of China Postal Savings Bank, said that most residential mortgage loans in China are long-term loans, and the interest rate is based on 5-year LPR (loan market quoted rate), while operating loans are mainly short-term loans, and the interest rate is based on 1-year LPR. The five-year LPR is higher than the one-year LPR. At the same time, for the purpose of supporting the development of small and micro enterprises, the interest rates of operating loans and consumer loans are lower, further expanding the arbitrage space.

However, it is worth noting that behind the seemingly "arbitrage", there are many hidden costs and risks hidden in the lending business.

Zhuo Ling told reporters that when communicating with a number of intermediaries until the signing of the contract, he found that the actual interest rate reduction was not as cost-effective as expected, and there were many extra costs. On the one hand, the cost comes from "crossing the bridge" funds. According to the process, consumers need to use the bridge funds provided by the intermediary to settle the mortgage, and then go to the bank to apply for operating loans and return the bridge funds.

However, because the loan period is usually more than a week, or even as long as several months, the capital cost of crossing the bridge is not low. According to Zhuo Ling, at present, the daily interest rate of intermediary funds in the market is usually around "five thousand" (that is, five ten thousandths), which means that if you want to replace a 2.3 million yuan mortgage, you need to pay 1,150 yuan interest every day, and the interest for one month may be as high as 30,000 to 40,000 yuan.

On the other hand, these institutions usually charge a high service fee. The reporter contacted a number of intermediaries and found that the service fee is basically more than one point. For example, for a lending order of 1 million yuan, the service fee is at least about 10,000 yuan. In the process of borrowing business loans, if there is no business owner qualification or does not meet the corresponding requirements, "packaging" will require additional fees.

In addition to the high cost, the loan term is shorter after "lending", and the monthly supply pressure may increase instead of decreasing. A Dongguan owner who handled the re-lending business last year told the reporter that he changed the mortgage with an interest rate of 5.8% to a business loan of 3.8% at that time. The original loan was 3 million yuan, and the repayment was made by the equal principal and interest method for 30 years, with a monthly payment of more than 17,000 yuan. After being converted into a 10-year operating loan, it will pay back about 30,000 yuan per month. At the same time, it is also necessary to bear the risk of "lending". Once the bank examines that funds flow into the housing market illegally, it is necessary to fill the loan gap in a short period of time.

"The operation of lending to reduce interest rates is meaningless and risky." Yan Yuejin, research director of Yiju Research Institute, told the First Financial Reporter that such operations of transforming traditional mortgage business into business loans will "package" buyers as business owners. However, there are several problems. First, this kind of "packaging" also requires costs. Second, the operating loan period (mostly) is only 1-10 years, so the pressure of monthly loan repayment actually increases. Third, the post-loan inspection of banks will be stricter.

Regulators and banks have repeatedly warned.

Recently, banks in Henan, Hubei, Guizhou and other places have issued statements to remind consumers of the hidden risks in "lending to reduce interest rates" and handling loans, and at the same time stressed that bank loans have not cooperated with intermediaries.

For example, on October 7th, China Bank Guizhou Branch issued a notice in Guanwei, saying that illegal loan intermediaries would pretend to be "xx Bank" and "xx Bank Loan Center" to publish loan advertising information, or push the loan amount to consumers, claiming that "they have connections within the bank" and "they can apply for loans through internal processes" to trick consumers into handling loans through them. In fact, such intermediaries have nothing to do with banks, but only to trick borrowers into making false propaganda.

Dancheng Rural Credit Cooperative said in the announcement on October 7 that it has never cooperated with any intermediary agency or individual in loan intermediary business, nor has it authorized any third-party company or platform to carry out loan business; In the process of handling the loan business, no fees such as agency fee, service fee and mortgage registration fee are charged, except as stipulated in the contract.

In addition to banks, regulators have recently issued risk warnings. Ningxia Supervision Bureau of the State Financial Supervision and Administration Bureau issued a risk warning on preventing illegal loan intermediaries from infringing on the legitimate rights and interests of financial consumers in early October, which reminded consumers to enhance their awareness of risk prevention, be wary of unfamiliar phone calls or text messages to promote loan business in the name of "low interest and quick" and "approved loan amount", and do not provide sensitive personal information to others at will or authorize others to handle financial business at will.

As early as the end of 2022 and the beginning of 2023, the supervision focused on a round of rectification of loan intermediaries. At the end of 2022, the former China Banking and Insurance Regulatory Commission issued a risk warning that some unscrupulous intermediaries explored "business opportunities" and introduced mortgage loans to consumers. This operation of replacing mortgage with business loan hides risks such as illegal breach of contract, high charge trap, influence on personal credit information, capital chain break and infringement on information security. On February 2 this year, Shenzhen Real Estate Agency Association issued the "Solemn Reminder on Prohibiting Real Estate Agencies and Employees in the City from Participating in the Illegal Use of" Business Loans "; On February 13th, Liaoning Banking Insurance Regulatory Bureau issued "Risk Tips on Early Repayment of Loans or Lending", giving tips on the risks of operating loans and the norms of intermediary institutions.

Yan Yuejin believes that this kind of loan business is illegal in itself, and all localities still need to strengthen publicity, especially to strengthen the inspection of enterprise operation, to prevent all kinds of shell companies from taking such loan funds, and at the same time to increase control over intermediaries.

Shaanxi Higher People’s Court filed a case for review. The complainant has been released from prison for raping and killing a young girl 25 years ago.

Lu Tianhui (first from the right) and his complaint agent Deng Xueping (middle) took a group photo with the interviewee.

  Lu Tianhui, a man from Hanzhong, Shaanxi Province, was sentenced to life imprisonment because he was found to be the murderer of a young girl case 25 years ago. After commutation, he was released in January this year after more than 24 years in prison.

  After being released from prison, 55-year-old Lu Tianhui complained that he was not the murderer. On October 16th, The Paper learned from the relevant staff of Shaanxi Higher People’s Court that the court has initiated a case review of Lu Tianhui’s case, and it is not convenient to disclose the latest progress of the review.

  Many years ago, when the case was opened in the first instance, Lu Tianhui, who had made a guilty confession to the police, retracted his confession in court. Before the verdict was pronounced in the first instance, Hanzhong Intermediate People’s Court sent the case back for supplementary investigation four times, demanding to eliminate multiple doubts. The fourth decision on returning the investigation stated that "after many times of returning the investigation, the facts of this case were unclear and the evidence was insufficient", and there were many doubts and there was no statutory case.

  The police issued a number of "Notes" in this regard, and the case was finally decided. On May 21, 1999, after Lu Tianhui was detained for more than four years, Hanzhong Intermediate People’s Court pronounced the sentence in the first instance, and found Lu Tianhui guilty of intentional homicide and rape of a young girl, and sentenced him to life imprisonment. After Lu Tianhui appealed, the Shaanxi High Court made a final ruling in September of the same year and upheld the original judgment.

  The Paper noted that in the judgment of the first instance, the defender believed that Lu Tianhui was found guilty of adultery and murder of a young girl, based on indirect evidence such as on-site inquest and criminal scientific and technical appraisal, and suggested that the court should impose appropriate punishment. Hanzhong Intermediate People’s Court held that "the defender’s defense opinions can be adopted."

  Deng Xueping, Lu Tianhui’s appeal attorney, told The Paper after consulting the case file that there were many doubts in the case, and the most important thing was that the key evidence for finalizing the case was only blood group identification, and the result was not exclusive.

  According to the file data, in June 2004, due to Lu Tianhui’s complaint, Hanzhong Intermediate People’s Court filed a case for review. Yajun Gao, then the director of Sujiaying Police Station who handled the case, said in a telephone inquiry during the review of Hanzhong Intermediate People’s Court that the important evidence of Lu Tianhui’s case was blood, "blood proved that he killed the little girl". Five months after the investigation, Hanzhong Intermediate People’s Court decided to reject the complaint.

  The police locked the suspect by blood type identification.

  At 10 o’clock on the morning of September 4, 1994, the police of Hedongdian Police Station in Hantai District, Hanzhong City, Shaanxi Province received a report from the masses that a woman’s body was found in a paddy field by two groups of villagers in Hongqi Village, Hedongdian Town one day ago. When it was found, it was highly decomposed, leaving only the skeleton.

  The villagers remembered that more than 20 days ago, Lu Cun, a villager in the neighboring Quluying village, reported to the police that her only daughter Lu Li (a pseudonym) was missing. Lu Cun said in the missing report that on August 8, 1994, he and his wife went out to work, leaving his daughter to write at home. When he came home at noon, his daughter was gone. Until seven o’clock that night, Lu Li still didn’t go home. He and his wife began to look around.

  After the family members identified the clothes worn by the bones and compared them with the blood type, the police determined that the deceased was 10-year-old Lu Li. The Paper noticed that there was no DNA identification report on the identity of the female corpse and other evidence in the existing case files, and it was not mentioned in the list of evidence listed in the judgment.

  The autopsy report showed that the bone color of Luli’s right eyebrow arch, under the nasal bone and pubic symphysis became darker, which proved that she had suffered blunt injury before her death, but the cause of death could not be determined because of the high corruption of the body.

  The police once investigated many male villagers in the same village, but it was fruitless. Lu Tianhui, a young man living alone in the straw house of Changtan Forest Farm on the bank of Baohe River, caught the attention of the case handlers. The straw house is not far from where the body was found. The police found suspicious blood on the doorframe, brick pier, pillow and white shirt of Lu Tianhui’s residence. During the search, the police also found several obscene books and diaries with women’s names on them. Later, all these became evidence and appeared in several judgments in this case.

  Lu Tianhui told The Paper that he left home and lived alone because he and his mother were unhappy about family affairs, and at that time he often sifted sand on the river Bao during the day before moving to the thatched cottage. On the night of the murder, he went to the village accountant’s home to issue a remittance certificate. When he returned to the hut, it was past nine o’clock. After reading for a while, he fell asleep. He said that the white shirt found by the police was an old one he didn’t wear. It had not been washed for several months, and it was usually used to cover the quilt to prevent dust.

  The blood test certificate issued by HanzhONg Public Security Bureau on October 6, 1994 shows that the blood on the door frame and Lu Tianhui’s white shirt is ON type, which is the same as Lu Li’s hair and bone blood type, while Lu Tianhui’s blood type is AMN type.

  On October 15th of the same year, the police formally detained Lu Tianhui. The only notice of arrest on file shows that Lu Tianhui was taken away by the police for questioning on September 16, and in the following 30 days, the Hantai Branch made a total of nine transcripts. Deng Xueping believes that this does not comply with the provisions of the Criminal Procedure Law that "the maximum duration of summons and detention shall not exceed 12 hours".

  According to the investigation report, Lu Tianhui confessed the whole process of raping and killing Lu Li under the strong offensive of "repeated policy education" and "putting facts and reasoning" by the police. On October 22, Lu Tianhui was arrested by Hanzhong Public Security Hantai Branch for intentional homicide and rape.

  After the court returned the investigation for four times, the defendant was sentenced to life.

  In December 1994, Hanzhong City Procuratorate sued the case to Hanzhong Intermediate People’s Court, and in the following five years, Hanzhong Intermediate People’s Court returned the case for supplementary investigation four times.

  According to the four return letters in the case file, the court asked for supplementary investigation on the cause of Lu Li’s death, how the blood on the white shirt was formed, the process of blood extraction, whether there was a confession by torture, the possibility of excluding others from committing crimes and the evidence to confirm the facts of adultery. On November 24, 1998, Hanzhong Intermediate People’s Court made a decision to withdraw the investigation for the fourth time, saying that "after repeated withdrawals, the facts of this case were unclear and the evidence was insufficient", and there were many doubts and there was no statutory case. In this regard, the police issued a number of "Notes".

  On September 21, 1995, when the first trial of the case was held, Lu Tianhui retracted his confession in court, claiming that the guilty confession was made at the instigation of the case-handling personnel. After Lu Tianhui was detained for more than four years, on May 21, 1999, Hanzhong Intermediate People’s Court sentenced Lu Tianhui to life imprisonment for intentional homicide, 15 years imprisonment for adultery with a young girl, combined punishment for both crimes, and combined execution of life imprisonment.

  The judgment found that at 8: 00 pm on August 8, 1994, Lu Tianhui rode back to her residence and went to Doumen, Gaoyan. When she met Lu Li walking independently, she tricked her into a depression outside an old pumping station in Quluying Village Forest Farm and raped her. For fear of being exposed, Lu Tianhui covered Lu Li’s mouth with his left hand, pinched her neck with his right hand, kneeled her abdomen with her knees, and slammed a cement block on her forehead to death. After the murder, Lu Tianhui wrapped the body in a plastic woven bag, moved it to the rice field 150 meters away, pulled out some rice by hand, dug the pit by hand and buried the body, and then replanted the pulled rice.

  The Paper noted that in the list of physical evidence shown in the judgment, the cement block of the murder weapon and the woven bag of the corpse removal tool were not included. According to the file data, the police handling the case gave an explanation in October of the year of the incident, saying that the investigator "has not found it after more than two hours of serious search", and this handwritten case description was not stamped with the official seal.

  In addition to the confession, the most important evidence of the verdict is blood group identification. Deng Xueping, Lu Tianhui’s complaint agent, pointed out that according to the case file, the case-handling unit never extracted DNA from the bones, nor did it conduct DNA identification. Under this circumstance, it was impossible to confirm that the blood on Lu Tianhui’s white shirt and door frame came from Lu Li. "Blood type identification is not exclusive, and there is no direct evidence to prove that Lu Tianhui killed people."

  The Paper noted that the article "DNA identification technology and its application in criminal investigation" in the fourth issue of "China Judicial Appraisal" in 2007 recorded that since 1993, DNA identification technology has been widely used in criminal investigation in China.

  In June 1999, Lu Tianhui appealed because he refused to accept the judgment of the first instance. Three months later, the Shaanxi High Court made a final ruling, rejected his appeal application and upheld the original judgment.

  The Paper noted that in the defense opinions of the defenders of the first instance recorded in the judgment, it was mentioned that "the court was advised to impose appropriate punishment" on the grounds that Lu Tianhui was guilty of adultery and murder of a young girl, which was based on indirect evidence such as on-site inspection and criminal scientific and technical appraisal. Hanzhong Intermediate People’s Court held that "the defense opinions of defenders can be adopted."

  Deng Xueping believes that in the case that Lu Tianhui refused to plead guilty and repent and did not make any financial compensation, the sentence of combined punishment for two crimes was indefinite, "there is room for it."

  There is a big difference in the comparison data of footprints. The police said that they could not find similar conditions.

  The Paper noted that out of the nine transcripts made by Lu Tianhui to the police, there were two confessions of innocence and seven confessions of guilt. The first guilty confession was made on September 26, the tenth day after Lu Tianhui was arrested, and just one day later, Lu Tianhui made another innocent confession. In its seven guilty confessions, there are inconsistencies in the victim’s dress, his own dress, tools for committing crimes, the killing process, and the time of taking the tools for throwing the body.

  Lu Tianhui told The Paper that during the interrogation, he was tortured to extract a confession. Today, he still has two crimson scars on his calves.

  In the first instance of this case, Hanzhong Intermediate People’s Court also investigated whether there was a confession by torture, and Hantai Branch and investigators issued two written certificates to deny it.

  When Hanzhong Intermediate People’s Court sent the case back to the procuratorate for supplementary investigation for the fourth time, it asked Hantai Public Security Bureau to explain whether to compare the data of "Chengtangjiaowo" extracted during the investigation with that of Lu Tianhui. Hantai Branch issued a "Description" to the court five years after the case was detected, saying that "because the time, space and place that coincided with the original scene could not be found at that time, the measurement data were quite different".

  According to the "Description", the foot fossa found during the on-site investigation of the bones was 6 cm deep and 23 cm long, and the stride was 87 cm, while Lu Tianhui’s foot was 23.5 cm long. He was carrying stones equal to Lu Li’s weight, and the stride obtained after simulating barefoot natural walking twice in the sediment field near the original site was far less than 87 cm, namely: the first step: the left stride was 77 cm, 77 cm, 78 cm, and the right stride was 79. The second pass: the left step is 60 cm, 57 cm and 61 cm, and the right step is 65 cm, 61 cm and 63 cm.

  Deng Xueping therefore believes that the public security organs did not transfer the data that might prove Lu Tianhui’s innocence or light crime to the procuratorate for the first time.

  After being released from prison, he appealed and the Shaanxi High Court filed a case for review.

  In June 2004, due to Lu Tianhui’s persistent complaint, Hanzhong Intermediate People’s Court filed a case for review. According to the case file, when the organizer revisited the site on July 26 of that year, he personally went to the field to test and simulate the details of "pulling rice by hand". However, the conclusion was that after a night of heavy rain, the soil in the field was still hard, and the two feet stood on the mud, and they could only step down to the arch of the foot, or they could only step down to the outer edge of the back of the foot. Because the rice grew to a late stage and the roots were deep, the organizer could not pull rice by hand at all.

  Five months after the investigation, Hanzhong Intermediate People’s Court decided to reject the appeal. According to the case file, Yajun Gao, then the director of Sujiaying Police Station, said in a telephone inquiry during the reexamination of Hanzhong Intermediate People’s Court that the important evidence of Lu Tianhui’s case was blood, "blood proved that he killed the little girl".

  On October 18th this year, The Paper tried to contact Yajun Gao by telephone, but got no response.

  In January this year, after three commutes, after being detained for more than 24 years, Lu Tianhui was released from prison. He returned to his hometown to live with his mother and still insisted on appealing for himself.

  Lu Tianhui told The Paper that his father died young. As the eldest son of his family, he went home to farm after graduating from high school. At that time, his relatives used to act as matchmakers for him, but he couldn’t make it because of financial difficulties.

  On October 16th, The Paper learned from Shaanxi Higher People’s Court that the court had initiated a case review of Lu Tianhui’s case, and the relevant staff said that it was not convenient to disclose the latest progress of the review. (Reporter Wei Jiaming)

Huawei doesn’t need the Proposal, but don’t let Yu Dazui ruin a brand.

In 2017, Huawei seems to have a bad year. This Fortune 500 company, which has always enjoyed a high reputation among Chinese people, has been criticized by the public more than once, whether it is the rumored layoff plan for employees over 34 years old or Huawei P10, which has been caught in various negative rumors recently.

If the layoff plan for 34-year-old employees is not empirical and is an accident, then the problem of Huawei P10 is self-inflicted, and in the process of continuous fermentation, some untimely and arrogant remarks made by Huawei consumer BG CEO and chairman of Huawei Terminal Company Yu Chengdong have made the problem more and more serious.

The news about Huawei’s "flash door" is no stranger to everyone. The origin of the news is that some users found that Huawei used three different flash memories on P10, namely UFS2.1, UFS2.0 and EMMC5.1. In the previously released Huawei Mate 9, Huawei once used UFS2.1 as a selling point, which made those users who bought EMMC5.1 flash memories extremely dissatisfied. Not only is it a "flash door", before that, Huawei P10 was greatly annoyed by the lack of oleophobic layer, and this time, the "flash door" is even more like adding fuel to the fire.

Since then, in response to these incidents, Yu Chengdong’s arrogant attitude and so-called "a lot of speculation by friends and businessmen" have not only failed to calm public opinion and explain the problem clearly, but have unexpectedly contributed to the uncontrollable development of the incident.

As for why Yu Chengdong’s remarks have become an accelerant for the increasingly serious incident, we have to say that there is an unwritten rule in the circle of technology products.

In this industry, it seems that the boss of every manufacturer has his own "personal design" corresponding to his own products. To outsiders, this "personal design" of the boss can almost be equated with their products.

For example, Apple and Jobs, who have been mythologized, are both representatives of perfectionism. Lei Jun and his Xiaomi strive to present an engineer temperament to their users; Lao Luo and hammer, with the word "feelings" to fight the world; Yu Chengdong, relying on Huawei’s rapid sales and brand promotion in the past two years, has made amazing remarks frequently and got the nickname of "Yu Dazui".

Yu Chengdong’s outspokenness is actually a rare quality in this industry, especially those brave words about the future development prospects of Huawei’s mobile phones, which always make people believe in him.

However, if you talk too much, you will inevitably make mistakes, especially when Huawei is negatively involved.

Seeing that things still showed no signs of calming down, Yu Chengdong spoke again. Compared with the tough and arrogant attitude before, Mr. Yu seems to have bowed his head this time, seemingly apologizing, but he still adopts the names of "internal letter" and "proposal", and has not given a solution to "flash door" from beginning to end, showing a reluctance and a peace of mind.

Looking at the whole Proposal, we can see what we want in the future everywhere. Without mentioning a word about what happened before, we stated that we would set up a "consumer listening special action group", and during May Day, Yu Chengdong would personally lead a team to retail stores, service shops and stations to communicate with consumers at close range.

But what’s the point of such a "consumer listening task force" if you can’t even listen to the problems that have been raging on the Internet? Such an initiative can only be understood as "I know I’m wrong, but I’m not going to correct it, and I’m wrong if I was wrong before, and there’s nothing you can do about it."

Such a "proposal" is really not as good as none.

Since this proposal was issued, many people have classified it as a "stupid public relations" series, and the criticism against it is still endless. If there is no accident, Huawei may continue to make more responses.

However, can consumers wait for a real apology and a solution to the problem? Who can make Huawei and Yu Chengdong lower their heads?

In fact, the life of Huawei’s consumer business is not easy at present. As the CEO of consumer business, Yu Chengdong is under great pressure.

According to the 2016 annual report data released by Huawei, the most concerned consumer business achieved sales revenue of RMB 179.8 billion in 2016, up 43.6% year-on-year, and the annual smartphone shipments reached 139 million units, up 29% year-on-year. Compared with OPPO and vivo, which are chasing after each other, this kind of data is hard to say bright, and it also fails to meet Huawei’s own expectations.

At the same time, in 2016, Huawei’s net profit was 37.1 billion yuan, a year-on-year increase of only 0.4%. Therefore, on the one hand, the development of Huawei’s smart phone business encountered a bottleneck in the past year; on the other hand, "the profitability is still insufficient and the profit growth is too slow" became Ren Zhengfei’s biggest accusation against Yu Chengdong.

But even so, it cannot be the reason why Huawei is so arrogant to consumers, and such arrogance is likely to kill a domestic backbone brand that has been booming.

I think anyone who pays a little attention to the smart phone industry knows that Huawei’s goal is not only in the domestic market. Before, there was a slogan of "surpassing Apple in three years and surpassing Samsung in five years", but we know that this is a company with global ambitions. If you want to become a world-famous brand, you must have enough brand premium, and these brand premiums come not only from the product itself, but also from the recognition of consumers and the honest management of the enterprise itself.

However, like Huawei, frequent crises caused by consumers’ dissatisfaction with product quality are undoubtedly the most serious loss to the brand. Lessons from the past, such as Samsung Note 7, have been fully recalled, and Samsung S8 has also appeared, but until now, Samsung still can’t completely put aside the shadow of the battery explosion, and it can be expected that this topic will be a sore point for Samsung in the next year or two or even longer, and it will be repeatedly mentioned by users.

There is a well-known Tacitus trap in sociology, which means that when a government department or an organization loses its credibility, no matter telling the truth or lying, doing good or bad things, it will be considered as telling lies or doing bad things. The same is true for the brand building of enterprises. It is not easy to build a brand, but it is easy to destroy a brand. When the brand was destroyed, it was even more difficult to make a comeback.

At present, the negative effects caused by Huawei P10 are far from as serious as those caused by Samsung Note 7 at that time. However, looking back at history, those problems that were considered as major events were often ignored at the beginning, and it was not until they were finally irretrievable that they regretted not being able to contain the problems in the bud at the beginning.

The problems that Huawei is facing now may be such a bud. It is not too difficult to apologize and admit mistakes and provide some practical and reliable solutions. But why Huawei is unwilling to do so and bet on its own brand reputation is incomprehensible.

Is it really impossible for Huawei and Yu Chengdong to keep their heads down? Stubbornness and stubbornness are not the way to solve the problem. Don’t let Yu Chengdong destroy Huawei, a brand with unlimited possibilities.

How dare you wear such underwear and jacket? CCTV exposes those functional clothes that can cause cancer.

  CCTV News:Nowadays, there are not only many styles of clothing, but also functional clothing. The so-called functionality, such as moisture absorption, waterproof, quick drying, anti-bacteria, etc., sounds really good. However, a recent inspection by Shanghai Market Supervision Bureau found that not all functional clothing has functions, and the quality of some so-called functional clothing is not as good as ordinary clothing.

  [32% of functional clothing is unqualified]

  Shanghai Municipal Market Supervision Bureau released the latest results of functional clothing quality spot check, and the unqualified rate was 32%. This spot check involves 47 brands and 125 batches of functional clothing sold by 20 distribution companies. After testing, 40 batches of functional clothing were unqualified, of which 2 batches of functional clothing were found to be carcinogens.

  Xie Zhenghao, Deputy Director of Consumer Protection Department of Shanghai Municipal Market Supervision BureauThen these unqualified goods mainly involve two categories. The first category is that it does not meet the national mandatory standards. For example, it involves formaldehyde exceeding the standard. The second category is a function of its explicit functionality, and it has not achieved its explicit effect. Compared with its explicit index, it is very different from a value actually measured by it.

  The reporter analyzed the related complaints of Consumers Association about clothing in recent three years, and found that this kind of goods is a hot complaint, and it is one of the categories that consumers are most concerned about and have the highest number of complaints. The number of complaints about clothing, shoes and hats is between 40,000 and 60,000 each year. In 2018, the number of complaints related to clothing increased compared with 2017.

  Functional clothing is to design the required functions on clothes. Compared with ordinary clothing, functional clothing has higher quality and technical requirements. Most of the functions are realized by fabrics with functions.

  Ren Hening, Deputy Director of National Textile Products Quality Supervision and Inspection CenterIn recent years, a large number of functional clothes have appeared in the market, and the price of such clothes is often higher than that of our ordinary clothes. For example, our common moisture-absorbing and quick-drying clothing, waterproof and moisture-permeable clothing, anti-ultraviolet clothing, antibacterial clothing and so on. However, the phenomenon of uneven quality also appeared. In our opinion, some clothes are ordinary clothes, but they are also marked with functionality.

  [The price of unqualified functional clothing is usually several thousand yuan]

  The inspection was undertaken by the National Textile Products Quality Supervision and Inspection Center. At the inspection site, the reporter saw 40 batches of products that were judged unqualified in this spot check. After statistics, the reporter found that these 40 batches of unqualified products came from 21 brands.

  Unqualified products include pregnant women’s underwear, men’s and women’s underwear, sweaters, shirts, T-shirts, jackets, jackets and so on. The reporter found that the prices of these clothes are mostly in the thousands of dollars. The reporter checked the label of unqualified functional clothing and saw that its marked functions include ironing-free, antibacterial, moisture-absorbing and sweat-absorbing, quick-drying, waterproof and breathable, ultraviolet-proof and so on.

  The inspector told the reporter that as a functional garment, the function should of course be guaranteed. But at the same time, as the clothes that consumers wear every day, safety is the first. In this regard, the national standard stipulates that "decomposable carcinogenic aromatic amine dyes" that threaten human health are prohibited from being detected in clothing. However, to the reporter’s surprise, this banned harmful substance was still detected on some functional clothes.

  Ren Hang, Engineer of National Textile Products Quality Supervision and Inspection Center.This is an eluent containing decomposable carcinogenic aromatic amines. Decomposable carcinogenic aromatic amine, which is not directly added, is generally produced by prohibiting the decomposition of azo dyes.

  Inspectors told reporters that the decomposable carcinogenic aromatic amine dye in this container was found in this men’s jacket with the nominal brand POLO SPORT. The reporter checked the label of this functional clothing. Its nominal general agent in China is Shanghai Ruifa Clothing Co., Ltd., and its nominal origin is Shenzhen, Guangdong.

  The inspector further explained that the decomposable carcinogenic aromatic amine dye detected in this garment refers to the dye synthesized from carcinogenic aromatic amine, which is often called "banned azo dye". This banned azo dye is prohibited from being detected in all textiles.

  Ren Hang, Engineer of National Textile Products Quality Supervision and Inspection Center.In our national standard, the restrictions on decomposable carcinogenic aromatic amine dyes are forbidden. This kind of decomposable carcinogenic aromatic amines are mainly used in dyes, which will decompose carcinogenic aromatic amines in the process of normal wearing. After being absorbed by the human body through the skin, carcinogenic aromatic amines will cause sensitization, carcinogenesis and teratogenicity to the human body.

  That is to say, long-term wearing of this jacket, which has been found to decompose carcinogenic aromatic amine dyes, may change the structure and function of human cell DNA and induce cell canceration.

  Formaldehyde is a well-known carcinogen, but the toxicity and carcinogenicity of decomposable carcinogenic aromatic amines are far higher than formaldehyde in terms of clothing safety indicators. Because formaldehyde has a pungent smell, it is easy to distinguish and dissolve in water. Generally, clothes bought by consumers can be partially removed by washing with water. However, after the decomposable carcinogenic aromatic amine dye is made into clothing, its harm cannot be eliminated.

  Ren Hang, Engineer of National Textile Products Quality Supervision and Inspection Center.It is unlikely that the decomposable aromatic amine dye will be washed away by water, so its harm is persistent and may have caused certain damage to human body since the day it was bought.

Haikou responded that the dangerous building is still on the market for sale: the investigation procedure has been started and the responsibility will be seriously investigated.

  Yesterday (17th), Voice of China reported that a dangerous building in qiongshan district, Haikou City, Hainan Province was required to be demolished. As a result, not only was it not demolished, but it also became a regular commercial house. Now this building has been identified as a D-class dangerous building. The building is seriously tilted, and a bottle of mineral water on the ground in the room can roll. However, some residents still live in dangerous buildings because they are not properly resettled, and their lives are threatened. (previously reported)  

  After the report was broadcast, Haikou and qiongshan district responded immediately.On the morning of the same day, people were sent to resettle residents from dangerous buildings, and the suspected violations of laws and regulations during the relevant procedures were thoroughly investigated, and the responsibilities would be seriously investigated.

The latest response from the local street office: residents can live in resettlement houses.

Or subsidize 1000 yuan to rent his own house every month.

  Building 27, Qingzhu Street, qiongshan district, Haikou City, was built in 1993. At that time, it was approved to build three floors, but it was built to eight floors. In 2003, due to the serious inclination of the house, it was designated as a dangerous building by the former Planning and Construction Bureau of qiongshan district, and it was required to be demolished.

△ The dangerous building is seriously tilted, and the mineral water will roll.

  In 2007, this dangerous building, which had to be demolished, went through the formalities of commercial housing, and then went on the market. Until July 2022, this building was identified as a dangerous building again, and all residents were required to move out. However, after the residents were settled in the hotel for three months, no one took care of them, and some residents moved back to dangerous buildings to continue living.

  On the morning of the Voice of China report, many functional departments of qiongshan district came to the building downstairs.Resettlement of residents who are still living.    

  Street office staff:They are moving out today. Let them out first. There are dangers in this house.

△ After the report was broadcast, the staff came to work under the dangerous building.

  Residents of this building told reporters,Now the streets can live in resettlement houses according to their wishes, or enjoy the monthly subsidy from 1000 yuan to rent their own houses.

  Household:They said that you should put your mind at ease. Now this house must not be demolished, and it will be done after it is handled. Move out first. The government gives a family 1000 yuan a month, and we rent a house outside.

  Zhong Hongxia, member of the Standing Committee of Haikou qiongshan district District Committee and Minister of Propaganda Department, told the reporter that the first priority at present is to let residents move out of dangerous buildings and stay away from danger.Those who are willing to live in resettlement houses can move in immediately, and those who want to rent outside are also subsidized. The investigation of relevant responsible units such as the Housing and Construction Bureau has begun.But it takes time.

  Zhong Hongxia:We have all found housing outside for free for these original tenants, and we have provided some funds, but it is only a transitional period. We want to demolish and rebuild the house as soon as possible, because it takes time to involve some details.

△ Building 27, Qingzhu Street, on the left, can be seen to be obviously inclined.

Government of qiongshan district: WillConduct a thorough investigation

Seriously investigate the responsibility according to the law and regulations

  The government of qiongshan district said in a circular, "The responsible person of Fengxiang Street, which has poor control over dangerous buildings, will be held accountable.And instructed the relevant departments to thoroughly investigate the suspected violations of the dangerous building reflected by the masses in the process of approval, construction and sales.Seriously investigate the responsibility according to the law and regulations."

  Zhong Hongxia told reporters that who should pay for the demolition and reconstruction costs that residents are concerned about,If it is the responsibility of the construction applicant or the housing construction department in that year, then the relevant expenses should also be borne by the responsible person.

  Zhong Hongxia:Which department is this illegal approval and sales? Which link is it? Who has a problem? We will arrange for further accountability, for example, the contractor at the beginning. After investigation, if he violates the rules, he will bear the main responsibility. According to the law, he should pay the expenses.

  Voice of China will continue to pay attention to the progress of the incident.

Extreme star Zhao Zhijian: Hermes is not difficult to buy, and environmental protection is the most expensive luxury.

At the Chengdu Auto Show in 2023, Mr. Zhao Zhijian, the director of polar star sales and network development, was a guest at the smart travel booth.

As an ultra-luxury pure electric brand, Polar Star’s temperament is quite outstanding.

It cherishes feathers and disdains to become a plaything of price war, so it chooses [only increase but not decrease], instead of seesaw a few tens of thousands of yuan, Polar Star 4 chooses to give a high-value rights and interests gift package with the highest value of 130,000.

Obviously, it is the one who was really born on the track, but it soon put down the stubborn shelves that fuel performance brands often have. Because for polar star, the most important thing is not simply to beat competitors, but what is really needed in this era.

Green mountains and green waters seem ordinary and extraordinary.

Extreme star Zhao Zhijian Hermes is not difficult to buy, but environmental protection is the most expensive luxury-Figure 1

The following is an interview record.

 

Smart Travel: What are the highlights of Polar Star () booth at Chengdu Auto Show?

Zhao Zhijian: Polar Star of Chengdu Auto Show has brought two latest products. The first one is Polar Star 4, a pure electric high-performance SUV released at the auto show, with a price range of 349,800-533,800. There are six configurations, which bring different feelings to customers. Another car is the ultra-luxury pure electric SUV Polar Star 3, which was released at the European headquarters last October and is expected to be delivered next year.

Extreme star Zhao Zhijian Hermes is not difficult to buy, but environmental protection is the most expensive luxury-Figure 2

Smart Travel: What rights and benefits did Polar Star 4 offer to users?

Zhao Zhijian: At the Shanghai Auto Show, we started Xiaoding. This time, we brought the best gift to Chengdu Auto Show, providing a very competitive and attractive "Eight Planets" rights plan for the first batch of car owners who became Polar Star 4: In the power supply link, we provide free charging piles; In terms of price protection, we promise that before the end of 2024, Polar Star will have any price adjustment part, and the official will make up the difference for the first batch of car owners; According to the relevant documents issued by the state, from January 1, 2024, the purchase tax of pure electric vehicles exceeding 30,000 yuan will have the market floating policy borne by the users themselves, and Polar Star promises to make up the difference for the first batch of car owners; In terms of products, we also bring two very powerful free package upgrades to our customers: the first is the Polestar intelligent driver assistance system, which is 35,000 yuan in our official, and we provide it to car owners free of charge. In addition, consumers can get a NAPPA leather seat set worth 40,000 yuan with an additional 6,800 yuan. The configuration also includes massage ventilation for the front seats and headrest stereos for the main and auxiliary drivers. The original standard 12 Harman Kardon stereos will be increased to 16; In terms of after-sales, we will provide all the first car owners with lifetime free warranty and free basic maintenance for three times in three years, which means that from the perspective of the original car, the first car owners will hardly have any additional expenses within three years.

Extreme star Zhao Zhijian Hermes is not difficult to buy, but environmental protection is the most expensive luxury-Figure 3

Overall, our whole package has provided customers with practical value of more than 130,000 RMB. As a luxury pure electric brand, we don’t intend to make preferential sales promotion by lowering the price, which is still very harmful to the brand, but in order to show the sincerity of Polar Star, we only increase rather than decrease, and take out the rights and interests of equal value to let users feel the warmth of Polar Star.

Smart Travel: Polar Star 4 is about to be delivered. What kind of users are currently determined?

Zhao Zhijian: Since the Shanghai Auto Show, we have made an overall portrait survey of Xiaoding customers and prospective car owners. I can describe the general outline of the group. This is a group of young people who are mainly post-90 s and have great personality. They have a unique insight into aesthetics, a certain appreciation of art, a high degree of education, and a relatively high proportion of unmarried people. To sum up, they are such a group of young people who are unmarried at a young age and have high knowledge and high salary.

Smart Travel: Will the brand setting of a more exquisite niche have an impact on sales?

Zhao Zhijian: In the past, the China market did think that Polar Star was a relatively niche luxury brand, but after the adjustment of market strategy and the upgrading of consumption concept, especially in the special environment of tram brands, more and more consumers will not care so much about the degree of the brand, and even to some extent, the niche may become an advantage point to assist the brand’s goodwill. As a luxury brand, we are right about the target, so we will not pursue a particularly large amount, which means that we will not become a streetcar, and we can.

Smart Travel: At this conference, Polar Star announced that Polestar OS will be upgraded after delivery, and the outside world also has high expectations. What kind of experience will this system bring to users?

Zhao Zhijian: Polestar OS is a fusion product. Its underlying design is Flyme Auto, which integrates the original theme of Polestar, orange, icon and body texture, and integrates the intelligent interactive logic of Flyme Auto to realize the interconnection between mobile phone and car through Flyme Link super desktop. In the past, people knew more about Huawei’s HarmonyOS system, but I can confidently say that Flyme Auto is as excellent as Huawei HarmonyOS’s intelligent cockpit system, which realizes the interconnection of everything well.

Extreme star Zhao Zhijian Hermes is not difficult to buy, but environmental protection is the most expensive luxury-Figure 4

Smart Travel: If you were asked to describe the polar star brand with one trait, what would you choose?

Zhao Zhijian: I think there are two. First of all, Polar Star may be a brand new and young brand to China people, but in fact, it has a history of more than 70 years. It used to be a brand of a motorcade and achieved very good results in various competitions. Later, it was transformed from a brand of a motorcade to a brand of a car. In the era of oil cars, Polestar is actually a high-performance brand under Volvo, which exists like M series. Therefore, Polestar is actually the orthodox blood with track genes. Only the team of Polestar has these excellent products. This is the accumulation and inheritance of the course, and it is also the rare heritage of most high-performance super-running brands. The difference between old money and new rich.

On the other hand, I think the competition in this range comes from the understanding of the word "luxury". We think that at present, "environmental protection" is the most luxurious luxury on the planet, and it requires you to spend a lot of money, material resources and energy to maintain it. The mountains and rivers are seemingly ordinary and the most unusual. From the moment when Polestar was transformed into a pure electric product, its mission was environmental protection and sustainability. In the process of design and manufacture, we used as many environmental protection materials as possible, so Polar Star hopes to become a zero-carbon brand completely by 2030. We always believe that environmental protection is the scarcest and precious wealth in the world.

China successfully launched the first star of Galaxy Space.

Xinhua News Agency, Jiuquan, January 16 (Li Guoli, Zhao Jinlong) At 11: 02 on January 16, China successfully launched the first low-orbit broadband communication satellite in China, the Galaxy Space Launcher, with a communication capacity of 10Gbps at Jiuquan Satellite Launch Center. The satellite successfully entered the scheduled orbit and the mission was a complete success.

Galaxy Aerospace First Star is an internationally advanced low-orbit broadband communication satellite independently developed by Galaxy Aerospace (Beijing) Technology Co., Ltd., which adopts Q/V and Ka communication bands, has transparent forwarding communication capability at 10Gbps rate, and can provide users with broadband communication services through satellite terminals. After the satellite is in orbit, relevant technical and business verification will be carried out in orbit.

Kuaizhou-1A launch vehicle is a small solid launch vehicle developed by Aerospace Science and Technology Rocket Technology Co., Ltd., a subsidiary of China Aerospace Science and Technology Group Co., Ltd. Aerospace Sanjiang Group. It mainly provides launch services for low-orbit small satellites with high orbit accuracy, short preparation period and low launch cost. This is the eighth launch mission of the Kuaizhou-1A carrier rocket.